Get started
IMMURON LTDIMMURON LTDIMMURON LTD

IMMURON LTD

No trades
See on Supercharts
Overview
Financials News Ideas Technicals

ANW chart

Key stats

Market capitalization
‪13.75 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.01EUR
Net income
‪−2.31 M‬EUR
Revenue
‪1.10 M‬EUR
Shares float
‪190.66 M‬
Beta (1Y)
2.56

About IMMURON LTD

Sector
Health Technology
CEO
Steven Lydeamore
Headquarters
Carlton
Website
immuron.com
Founded
1994
ISIN
AU000000IMC7
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce at mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994 and is headquartered in Carlton, Australia.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ANW is 0.06 EUR — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange IMMURON LTD stocks are traded under the ticker ANW.
IMMURON LTD is going to release the next earnings report on Aug 30, 2024. Keep track of upcoming events with our Earnings Calendar.
ANW stock is 0% volatile and has beta coefficient of 2.56. Check out the list of the most volatile stocks — is IMMURON LTD there?
Yes, you can track IMMURON LTD financials in yearly and quarterly reports right on TradingView.
ANW stock has fallen by 5.88% compared to the previous week, the month change is a 4.92% rise, over the last year IMMURON LTD has showed a 23.08% increase.
ANW net income for the last quarter is ‪−1.28 M‬ EUR, while the quarter before that showed ‪−1.10 M‬ EUR of net income which accounts for −15.82% change. Track more IMMURON LTD financial stats to get the full picture.
Today IMMURON LTD has the market capitalization of ‪13.75 M‬, it has decreased by 14.99% over the last week.
No, ANW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ANW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMMURON LTD stock right from TradingView charts — choose your broker and connect to your account.
ANW reached its all-time high on Jul 21, 2020 with the price of 0.50 EUR, and its all-time low was 0.03 EUR and was reached on Mar 25, 2020.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMMURON LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMMURON LTD stock shows the buy signal. See more of IMMURON LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.